Prognostic value of lymph node dissections in bladder cancer treated with radical cystectomy;Valeur pronostique du curage ganglionnaire lors des cystectomies totales pour cancer de la vessie

Progres en Urologie

Volumn 18, Issue 6, 2008, Pages 351-357

  Braud, G ^a   Battisti, S ^a   Karam, G ^a   Bouchot, O ^a   Rigaud, J ^a  

^a HÔTEL DIEU   (France)

Author keywords

Bladder cancer; Cystectomy; Lymph node dissection; Urothelial tumor

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; COMPARATIVE STUDY; CYSTECTOMY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; TIME;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 44949199311     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2008.02.007     Document Type: Article

References (20)

1. Irani J., Bernardini S., Bonnal J.L., Chauvet B., Colombel M., Davin J.L., et al. Recommandations 2007 en onco-urologie : Tumeurs urothéliales. Prog Urol 17 6 (2007) 1065-1098
2. Stein J.P., Cai J., Groshen S., and Skinner D.G. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170 1 (2003) 35-41
3. Vieweg J., Gschwend J.E., Herr H.W., and Fair W.R. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161 2 (1999) 449-454
4. Herr H.W., Bochner B.H., Dalbagni G., Donat S.M., Reuter V.E., and Bajorin D.F. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 3 (2002) 1295-1298
5. Poulsen A.L., Horn T., and Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160 6 Pt 1 (1998) 2015-2019 discussion 2020
6. Zerbib M., and Bouchot O. Les traitements des tumeurs infiltrantes de vessie : envahissement ganglionnaire pN+ et cystectomie totale. Prog Urol 12 5 (2002) 931-939
7. Mills R.D., Turner W.H., Fleischmann A., Markwalder R., Thalmann G.N., and Studer U.E. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166 1 (2001) 19-23
8. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A.C., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 3 (2001) 666-675
9. Skinner E.C., Stein J.P., and Skinner D.G. Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol 25 1 (2007) 66-71
10. Brossner C., Pycha A., Toth A., Mian C., and Kuber W. Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU Int 93 1 (2004) 64-66
11. Saint F. Recommandations du comité de cancérologie de l'association française d'urologie : curage ganglionnaire et cystectomie. Prog Urol (2005) 1095-1098
12. Herr H.W., Smith J.A., and Montie J.E. Standardization of radical cystectomy: time to count and be counted. BJU Int 94 4 (2004) 481-482
13. Leissner J., Ghoneim M.A., Abol-Enein H., Thuroff J.W., Franzaring L., Fisch M., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171 1 (2004) 139-144
14. Leissner J., Hohenfellner R., Thuroff J.W., and Wolf H.K. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85 7 (2000) 817-823
15. Konety B.R., Joslyn S.A., and O'Donnell M.A. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 169 3 (2003) 946-950
16. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 169 3 (2003) 943-945
17. Fleischmann A., Thalmann G.N., Markwalder R., and Studer U.E. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol 29 1 (2005) 89-95
18. Bouchot O., and Zerbib M. Les traitements des tumeurs infiltrantes de vessie : chimiothérapie néo-adjuvante et adjuvante à un traitement radical. Prog Urol 12 5 (2002) 987-997
19. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48: 189-199.
20. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48: 202-205.